Key Advances in Endometrial Cancer

home / insights / key-advances-in-endometrial-cancer

Endometrial Cancer Incidence and Risk Classification

EP. 1: Endometrial Cancer Incidence and Risk Classification

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
January 29th 2021
Genomic Assessments for Metastatic Disease

EP. 2: Genomic Assessments for Metastatic Disease

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
January 29th 2021
Treatment Challenges: Advanced Endometrial Cancer

EP. 3: Treatment Challenges: Advanced Endometrial Cancer

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
February 4th 2021
Adjuvant Chemotherapy +/- Radiotherapy: Recent Data

EP. 4: Adjuvant Chemotherapy +/- Radiotherapy: Recent Data

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
February 4th 2021
Second-Line Checkpoint Inhibitor for MSI-H Disease

EP. 5: Second-Line Checkpoint Inhibitor for MSI-H Disease

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
February 4th 2021
GARNET Clinical Trial Regimen in Advanced Disease

EP. 6: GARNET Clinical Trial Regimen in Advanced Disease

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
February 4th 2021
Rationale for Combination Therapy in Advanced EC

EP. 7: Rationale for Combination Therapy in Advanced EC

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
February 4th 2021
Safety/Efficacy Results From EC Cohort of KEYNOTE-146

EP. 8: Safety/Efficacy Results From EC Cohort of KEYNOTE-146

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
February 4th 2021
Impact of Pembrolizumab/Lenvatinib Approval in EC

EP. 9: Impact of Pembrolizumab/Lenvatinib Approval in EC

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
February 4th 2021
Therapy Sequencing Through Multiple Lines of Therapy in EC

EP. 10: Therapy Sequencing Through Multiple Lines of Therapy in EC

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
February 4th 2021
Novel Strategies in Development for EC Management

EP. 11: Novel Strategies in Development for EC Management

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
February 4th 2021
Promising Novel Targets for Endometrial Cancer Management

EP. 12: Promising Novel Targets for Endometrial Cancer Management

Kathleen Moore, MD, Stephenson Cancer Center;David M. O'Malley, MD, The Ohio State University
February 4th 2021
Experts on MDS

EP. 13: Case 2 Discussion and Considerations for Second-Line Treatment Selection

Thomas Cluzeau, MD, PhD;Guillermo Garcia-Manero, MD;Rami D. Komrokji, MD;Sanam Loghavi, MD;Uwe Platzbecker, MD
February 16th 2023